Skip to content

Role of Gambhari phal in acute urticaria

Randomised comparative clinical study of Gambhari phal ( Gmelina arborea linn) with and without pathya in sheetpitta with special reference to acute urticaria - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078511
Enrollment
80
Registered
2024-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L500- Allergic urticaria

Interventions

None listed

Sponsors

Punam Navnath Pawar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patient will be selected irrespective of gender, religion, occupation, marital status. Patients with classical symptoms of Sheetpitta Viz Mandala, Utsedha, Toda, Daha, Kandu, Chardi are included in our study. Patients with acute Urticaria(It lasts for less than six weeks). Patients above the age of 16 years and below the age of 60 years.

Exclusion criteria

Exclusion criteria: Drug induced Urticaria. Patients having history of any chronic diseases .e.g. Heart diseases, paraplegia, diabetes mellitus, hypertensive, Cronic kidney disease etc. Patients having the symptom of Jwara are excluded.

Design outcomes

Primary

MeasureTime frame
With pathya gambhari phal is more effective in sheetpittaTimepoint: 30 days

Secondary

MeasureTime frame
Without pathya gambhari phal is more effective in sheetpittaTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Aniket Joshi

LRP Ayurved Medical College and Hospital, Post Graduate and Institute and Reseach centre,Islampur

vdaniket@gmail.com9890890889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026